Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
ACS Applied Materials & Interfaces|April 18, 2018
Using an Engineered Galvanic Redox System to Generate Positive Surface Potentials that Promote Osteogenic FunctionsYulong Zhang, Zhong Zheng, Mengliu Yu, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2019
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing settingKari M Morrissey, Mathilde Marchand, Hina Patel, et al.
Biomaterials|July 15, 2022
Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regenerationJustine Tanjaya, Pin Ha, Yulong Zhang, et al.
Lab on a Chip|September 22, 2005
Detection of picomolar levels of interleukin-8 in human saliva by SPRChu-Ya Yang, Evan Brooks, Yang Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2025
Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung CancerPhyllis Chan, Stephanie N Liu, Nathalie Gosselin, et al.
Advances in Therapy|February 2, 2026
Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual TherapyDaniel Lachant, Amresh Raina, Mrinalini Krishnan, et al.
The European Respiratory Journal|June 6, 2020
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasisMartina Oriano, Andrea Gramegna, Leonardo Terranova, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradationJia Chang, Fei Liu, Min Lee, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Automation of Lung Ultrasound Interpretation via Deep Learning for the Classification of Normal versus Abnormal Lung Parenchyma: A Multicenter StudyRobert Arntfield, Derek Wu, Jared Tschirhart, et al.
Pageof 16